Members |
targetComponentId |
Child: agency involved NOS |
Child agency involvement status |
Child: agency involved NOS |
Child agency involvement status |
Childhood epilepsy with occipital paroxysms |
Occipital lobe epilepsy |
Childhood seizure |
Seizure |
Chilognatha |
Class Diplopoda (organism) |
Chinese restaurant syndrome |
Monosodium glutamate symptom complex comprises of a set of symptoms with onset after ingestion of monosodium glutamate. The symptoms include migraine headache, urticaria, angioedema or rhinitis. |
Chlamydia pneumoniae deoxyribonucleic acid |
Chlamydophila pneumoniae DNA |
Chloral hydrate 250mg/5mL syrup |
Chloral hydrate 50 mg/mL oral solution |
Chloral hydrate suppositories 10gr |
Chloral hydrate 650 mg rectal suppository |
Chloral hydrate suppositories 5gr |
Chloral hydrate 325 mg rectal suppository |
Chloral sedative agent |
Chloral derivative (substance) |
Chloramin T specific extract |
Product containing tosylchloramide sodium (medicinal product) |
Chloramphenicol (class of antibiotic, substance) |
Chloramphenicol (substance) |
Chloramphenicol 0.25% eye drops |
Chloramphenicol (as chloramphenicol sodium succinate) 2.5 mg/mL eye solution |
Chlorhexidine |
Product containing chlorhexidine (medicinal product) |
Chlorhexidine digluconate+amethocaine 0.05/0.015% oral spray |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
Chlorhexidine gluconate 0.02% in 70% IMS spray |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
Chlorhexidine gluconate 0.02% in 70% IMS spray refill |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
Chlorhexidine gluconate 0.5% in 70% IMS solution |
Chlorhexidine gluconate 50 mg/mL cutaneous solution |
Chlorhexidine gluconate 0.5% in 70% IMS spray |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Chlorhexidine gluconate 0.5% in 70% IMS spray refill |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Chlorhexidine gluconate 2%/isopropyl alcohol 70% topical sponge |
Product containing only chlorhexidine and isopropyl alcohol (medicinal product) |
Chlorhexidine gluconate 3.15%/isopropyl alcohol 70% topical swab |
Product containing only chlorhexidine and isopropyl alcohol (medicinal product) |
Chlorhexidine gluconate+ethyl alcohol 1%/61% solution |
Product containing only chlorhexidine and ethanol (medicinal product) |
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% conventional release oromucosal spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
Chlorhexidine gluconate+lignocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
Chlorhexidine gluconate+sodium nitrite 0.5/0.1% in 70% IMS solution |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Chlorhexidine hydrochloride+neomycin sulfate |
Product containing chlorhexidine and neomycin (medicinal product) |
Chlorinated phenol disinfectant adverse reaction |
Chlorinated phenol adverse reaction |
Chlorinated phenol disinfectant allergy |
Allergy to chlorinated phenol (finding) |
Chlorobenzoic acid toxicity |
Poisoning by 4-chlorobenzoic acid |
Chloroform substance of abuse - non-pharmaceutical |
Chloroform |
Chlorophenothane |
Clofenotane |
Chloroprocaine hydrochloride 1% injection solution ampule |
Product containing only chloroprocaine (medicinal product) |
Chloroprocaine hydrochloride 2% injection solution ampule |
Product containing only chloroprocaine (medicinal product) |
Chloroprocaine hydrochloride 3% injection solution ampule |
Product containing only chloroprocaine (medicinal product) |
Chloroxylenol |
Chloroxylenol (substance) |
Chlorpheniramine 2mg/ibuprofen 200mg/pseudoephedrine 30mg caplet |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
Chlorpheniramine 2mg/ibuprofen 200mg/pseudoephedrine 30mg conventional release oral tablet |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
Chlorpheniramine maleate |
Product containing chlorphenamine (medicinal product) |
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg m/r tablet |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
Chlorpheniramine maleate + pseudoephedrine hydrochloride |
Product containing chlorphenamine and pseudoephedrine (medicinal product) |
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule |
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule |
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
Chlorpromazine hydrochloride 10mg/5mL syrup |
Chlorpromazine hydrochloride 2 mg/mL oral solution |
Chlorpromazine hydrochloride 150mg m/r capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorpromazine hydrochloride 150mg prolonged-release oral capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorpromazine hydrochloride 30mg m/r capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorpromazine hydrochloride 30mg prolonged-release oral capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorpromazine hydrochloride 50mg/5mL syrup |
Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Chlorpromazine hydrochloride 75mg m/r capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorpromazine hydrochloride 75mg prolonged-release oral capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorprothixene overdose |
Chlorprothixene overdose (disorder) |
Chlortetracycline hydrochloride 3% ointment |
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Cholangiogram normal |
Fluoroscopic cholangiography with contrast normal |
Cholangiogram normal post-cholecystectomy |
Postoperative fluoroscopic cholangiography with contrast normal |
Cholangiogram normal post-sphincterotomy |
Postoperative fluoroscopic cholangiography with contrast normal |
Cholecystectomy and operative cholangiogram |
Cholecystectomy with intraoperative fluoroscopic cholangiography with contrast (procedure) |
Cholecystectomy with exploration of common duct with cholangiography |
Cholecystectomy and exploration of common bile duct with intraoperative fluoroscopic cholangiography with contrast (procedure) |
Cholecystocholangiogram |
Percutaneous transhepatic fluoroscopic cholecystocholangiography with contrast |
Choledochotomy - obstruction NOS |
Incision of common bile duct |
Choledochotomy - obstruction NOS |
Incision of common bile duct |
Cholelithiasis NOS |
Biliary calculus |
Cholelithiasis NOS |
Biliary calculus |
Cholera vaccination NOS |
Administration of cholera vaccine |
Cholera vaccination NOS |
Administration of cholera vaccine |
Cholesteatoma with complications |
Cholesteatoma |
Cholesterol analyte |
Cholesterol |
Cholesterol reduction program - declined |
Cholesterol reduction programme declined |
Cholestyramine + sucrose |
Product containing colestyramine (medicinal product) |
Cholestyramine 4g powder |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g suspension |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g/unit powder |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g/unt powder |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine+aspartame |
Product containing colestyramine (medicinal product) |
Cholestyramine+aspartame 4g/sachet powder |
Colestyramine 4 g powder for oral suspension sachet |
Choline salicylate 870mg/5ml liquid |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) |
Choline salicylate+glycerol 20%/12.6% ear drops |
Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) |
Choline theophyllinate allergy |
Allergy to theophylline (finding) |
Chondrocalcinosis due to dicalcium phosphate crystals, NOS |
Chondrocalcinosis caused by dicalcium phosphate crystals |
Chondrocalcinosis due to dicalcium phosphate crystals, of other specified site |
Chondrocalcinosis caused by dicalcium phosphate crystals |
Chondrocalcinosis due to dicalcium phosphate crystals, of unspecified site |
Chondrocalcinosis caused by dicalcium phosphate crystals |
Chondrocyte cell |
Chondrocyte (substance) |
Chondrosarcoma - category |
Chondrosarcoma |
Chondrosarcoma, no International Classification of Diseases for Oncology subtype |
Chondrosarcoma |
Choriocarcinoma, no International Classification of Diseases for Oncology subtype |
Choriocarcinoma (morphologic abnormality) |
Choriogonadotropin alfa 10,000iu powder and solvent for injection solution ampule |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 1500iu powder and solvent for injection solution ampule |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 2000iu powder and solvent for injection solution ampule |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 5000iu powder and solvent for injection solution ampule |
Product containing only choriogonadotropin (medicinal product) |
Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule |
Product containing only choriogonadotropin (medicinal product) |
Choroid meningioma |
Meningioma, chordoid (morphologic abnormality) |
Choroid plexus papilloma, no International Classification of Diseases for Oncology subtype |
Benign choroid plexus papilloma (morphologic abnormality) |
Choroideremia co-occurrent with hypopituitarism |
An X-linked retinal dystrophy characterized by choroideremia, causing in affected males progressive nyctalopia and eventual central blindness. Obesity, moderate intellectual disability and congenital mixed (sensorineural and conductive) deafness are also observed. Female carriers show typical retinal changes indicative of the choroideremia carrier state. |
Chromic phosphate, p-32 15mCi injection suspension 10mL vial |
Chromic phosphate (32-P) only product in parenteral dose form |